tiprankstipranks
Enfusion (ENFN)
NYSE:ENFN
US Market

Enfusion (ENFN) Technical Analysis

Compare
35 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Enfusion’s (ENFN) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Enfusion is a Buy.
Enfusion’s (ENFN) 20-Day exponential moving average is 11.11, while Enfusion’s (ENFN) share price is $11.5, making it a Buy.
Enfusion’s (ENFN) 50-Day exponential moving average is 10.77, while Enfusion’s (ENFN) share price is $11.5, making it a Buy.

Enfusion (ENFN) Pivot Points

Feb 22, 2025, 04:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.63
10.96
11.15
11.48
11.67
12.00
12.19
Fibonacci
10.96
11.16
11.28
11.48
11.68
11.80
12.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enfusion (ENFN) Moving Averages

Feb 22, 2025, 04:32 PM
Period
Simple
Exponential
MA5
11.21Buy
11.28Buy
MA10
11.16Buy
11.21Buy
MA20
11.16Buy
11.11Buy
MA50
10.81Buy
10.77Buy
MA100
10.09Buy
10.28Buy
MA200
9.42Buy
9.73Buy
Enfusion’s (ENFN) 10-Day exponential moving average is 11.21, while Enfusion’s (ENFN) share price is $11.5, making it a Buy.
Enfusion’s (ENFN) 100-Day exponential moving average is 10.28, while Enfusion’s (ENFN) share price is $11.5, making it a Buy.
Enfusion’s (ENFN) stock price is $11.5 and Enfusion’s (ENFN) 50-day simple moving average is 10.81, creating a Buy signal.
Enfusion’s (ENFN) stock price is $11.5 and Enfusion’s (ENFN) 100-day simple moving average is 10.09, creating a Buy signal.
Enfusion’s (ENFN) stock price is $11.5 and Enfusion’s (ENFN) 200-day simple moving average is 9.42, creating a Buy signal.

Enfusion (ENFN) Technical Indicators

Feb 22, 2025, 04:32 PM
Name
Value
Implied Action
RSI (14)
66.62
Neutral
STOCH (9,6)
52.54
Neutral
STOCHRSI (14)
52.54
Neutral
MACD (12,26)
0.14
Buy
ADX (14)
27.37
Neutral
Williams %R
-34.09
Buy
CCI (14)
278.57
Sell
ATR (14)
0.22
-
Ultimate Oscillator
50.29
Neutral
ROC
3.05
Buy
Enfusion’s (ENFN) Relative Strength Index (RSI) is 66.62, creating a Neutral signal.
Enfusion’s (ENFN) Trend Strength Indicator (ADX) is 27.37, creating a Neutral signal.
Enfusion’s (ENFN) Commodity Channel Index (CCI) is 278.57, creating a Sell signal.
Enfusion’s (ENFN) Price Rate of Change (ROC) is 3.05, creating a Buy signal.

FAQ

Is ENFN a Buy, Hold, or Sell?
Based on ENFN’s technical indicators, ENFN is a Strong Buy.
    What is ENFN’s RSI (14)?
    ENFN’s RSI (14) is 66.62, which suggests ENFN is a Neutral.
      What is ENFN’s MACD?
      ENFN’s MACD is 0.14, which suggests ENFN is a Buy.
        What is ENFN’s 5-day moving average?
        ENFN’s 5-day moving average is 11.21, which suggests ENFN is a Buy.
          What is ENFN’s 20-day moving average?
          ENFN 20-day moving average is 11.16, which suggests ENFN is a Buy.
            What is ENFN’s 50-day moving average?
            ENFN’s 50-day moving average is 10.81, which suggests ENFN is a Buy.
              What is ENFN’s 200-day moving average?
              ENFN’s 200-day moving average is 9.42, which suggests ENFN is a Buy.
                What is ENFN’s Williams % R (14)?
                ENFN’s Williams % R (14) is -34.09, which suggests ENFN is a Buy.
                  What is ENFN’s CCI (14)?
                  ENFN’s CCI (14) is 278.57, which suggests ENFN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis